Synthetic Peptide
IFN-beta Synthetic Peptide, PEP-0507, from Invitrogen.
Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-176370 |
| Réf. fabricant | 15368620 |
| Gene ID (Entrez) | 3456 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | P01574 |
| Nom usuel | Human IFN beta |
| Concentration | 1 mg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | IFNB1 |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
